Free Trial

National Pension Service Has $33.33 Million Holdings in Avantor, Inc. (NYSE:AVTR)

Avantor logo with Medical background

National Pension Service grew its stake in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 5.7% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,288,319 shares of the company's stock after acquiring an additional 69,818 shares during the period. National Pension Service owned 0.19% of Avantor worth $33,329,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of AVTR. Robeco Institutional Asset Management B.V. increased its holdings in Avantor by 45.3% in the third quarter. Robeco Institutional Asset Management B.V. now owns 86,225 shares of the company's stock worth $2,231,000 after buying an additional 26,884 shares during the last quarter. Norris Perne & French LLP MI grew its position in Avantor by 0.6% in the third quarter. Norris Perne & French LLP MI now owns 491,696 shares of the company's stock worth $12,720,000 after acquiring an additional 2,876 shares in the last quarter. US Bancorp DE increased its stake in shares of Avantor by 6.2% during the 3rd quarter. US Bancorp DE now owns 12,615 shares of the company's stock worth $326,000 after purchasing an additional 734 shares during the last quarter. New York State Teachers Retirement System bought a new position in shares of Avantor during the 3rd quarter valued at $8,473,000. Finally, Wilson Asset Management International PTY Ltd. lifted its stake in shares of Avantor by 18.1% in the 3rd quarter. Wilson Asset Management International PTY Ltd. now owns 757,032 shares of the company's stock valued at $19,584,000 after purchasing an additional 115,880 shares during the last quarter. 95.08% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Barclays cut their target price on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a report on Friday, October 25th. Robert W. Baird reduced their target price on Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a report on Monday, October 28th. Citigroup downgraded Avantor from a "buy" rating to a "neutral" rating and lowered their price target for the company from $30.00 to $23.00 in a report on Wednesday, July 10th. Wells Fargo & Company reduced their price objective on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating for the company in a research note on Monday, October 28th. Finally, UBS Group lowered their target price on shares of Avantor from $30.00 to $29.00 and set a "buy" rating on the stock in a research note on Tuesday, October 8th. Three equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $27.57.

Get Our Latest Research Report on Avantor

Avantor Stock Performance

AVTR traded up $0.03 during trading on Thursday, reaching $23.00. 4,366,096 shares of the company's stock were exchanged, compared to its average volume of 6,415,638. The company has a market capitalization of $15.65 billion, a P/E ratio of 50.00, a PEG ratio of 2.70 and a beta of 1.35. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The business has a 50 day moving average price of $25.03 and a 200 day moving average price of $24.14. Avantor, Inc. has a fifty-two week low of $18.08 and a fifty-two week high of $28.00.

Insider Activity

In related news, CAO Steven W. Eck sold 3,525 shares of the firm's stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the transaction, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by company insiders.

Avantor Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Further Reading

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

→ War on Elon Escalates… (From Porter & Company) (Ad)

Should you invest $1,000 in Avantor right now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar
Top 3 Stocks Under $20 with Strong Buy Ratings and Growth Potential
ISRG Stock Surges: AI and Healthcare Innovation at the Core

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines